New trial data suggest dietary fiber supplementation may lower systolic blood pressure in adults with type 2 diabetes and hypertension.
Read More »Type 2 Diabetes Damages the Pancreas, Or Does It?
New research challenges assumptions about the exocrine pancreas in type 2 diabetes and what pancreatic findings may mean for clinical care.
Read More »Can Psychotherapy Lower Blood Sugar? New Evidence Finds a Link Between Mind and Metabolism
Discover how psychotherapy for type 2 diabetes may improve A1C, support self-management, and influence weight and metabolic health.
Read More »Can Resistant Starch Lower Your Next Blood Sugar Spike? Inside the “Second-Meal Effect”
Could the carbohydrates eaten at breakfast affect the blood sugar response to lunch? Research on resistant starch and the second-meal effect suggests they might. Resistant starch escapes much of the digestion that normally occurs in the small intestine. As a result, less of it is immediately converted to glucose, while …
Read More »Frozen Shoulder and Diabetes: The Overlooked Complication That Can Steal Mobility
Diabetes complications are often discussed in terms of the heart, kidneys, eyes, and nerves. However, diabetes can also affect joints and connective tissue. Adhesive capsulitis, or frozen shoulder, is one diabetes-related complication that deserves more attention. It can begin with ordinary shoulder pain and gradually make simple movements surprisingly difficult. …
Read More »Low Potassium, Higher Diabetes Risk? A Surprising Clue From Heart Failure Research
Low potassium is usually viewed through a cardiovascular lens, especially in patients with heart failure. However, emerging evidence suggests clinicians may have another reason to pay attention. New research examining the relationship between hypokalemia and diabetes risk found that lower serum potassium levels were associated with a greater risk of …
Read More »Could a Simple Blood Test Predict a Heart Event in Type 2 Diabetes?
Could a routine blood sample someday reveal cardiovascular danger that cholesterol, blood pressure, and HbA1c do not fully capture? New research suggests that epigenetic cardiovascular risk prediction could offer a new way to identify people with type 2 diabetes who face a higher short-term risk of major cardiovascular events. Instead …
Read More »GLP-1s and Opioids: The GI Risk Clinicians May Be Missing
GLP-1 receptor agonists have transformed the treatment of type 2 diabetes, but their effects on gastrointestinal motility remain an important clinical consideration. Opioids can also slow gastrointestinal function, raising an obvious question: what happens when patients need both? New research examining GLP-1 and opioid interactions suggests that opioid choice may …
Read More »Dialysis Changes the Rules: What Happens When Patients With Diabetes Use Real-Time CGM?
Managing glucose is rarely simple for people with Type 2 diabetes who receive maintenance hemodialysis. Dialysis can change glucose patterns, insulin needs, and the reliability of familiar measures such as A1C. As a result, clinicians may have an incomplete picture when making treatment decisions. New randomized research on CGM use …
Read More »A1C Has a Blind Spot: Could Glycated Albumin Help Clinicians Act Faster?
A1C is one of the most useful tools in diabetes care, but it has an important limitation: it takes time to reflect change. Could a faster-moving marker help clinicians know sooner whether treatment is working? New randomized research on glycated albumin in diabetes offers an intriguing answer. Glycated albumin reflects …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.